T. Rowe Price Associates
PHAS

T. Rowe Price Associates’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

T. Rowe Price Associates’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$2.46M Sell
2020
Q1 		$1.96M Sell
2019
Q4 		$4.36M Sell
2019
Q3 		$3.13M Sell
2019
Q2 		$10.4M Buy
2019
Q1 		$6.2M Buy
2018
Q4 		$2.01M Buy